Cargando…
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
BACKGROUND: Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the...
Autores principales: | Elad, Sharon, Cheng, Karis Kin Fong, Lalla, Rajesh V., Yarom, Noam, Hong, Catherine, Logan, Richard M., Bowen, Joanne, Gibson, Rachel, Saunders, Deborah P., Zadik, Yehuda, Ariyawardana, Anura, Correa, Maria Elvira, Ranna, Vinisha, Bossi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540329/ https://www.ncbi.nlm.nih.gov/pubmed/32786044 http://dx.doi.org/10.1002/cncr.33100 |
Ejemplares similares
-
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
por: Lalla, Rajesh V., et al.
Publicado: (2014) -
Abstracts of the MASCC/ISOO Annual Meeting 2018
Publicado: (2018) -
Abstracts for MASCC/ISOO Annual Meeting 2019
Publicado: (2019) -
Abstracts for MASCC/ISOO Annual Meeting 2021
Publicado: (2021) -
Abstracts for MASCC/ISOO Annual Meeting 2022
Publicado: (2022)